IBEX Technologies Inc.: IBEX Reports Results for the Second Quarter and Six Months Ended January 31, 2024
MONTRÉAL, March 22, 2024 (GLOBE NEWSWIRE) -- IBEX Technologies Inc. ("IBEX" or the "Company") (TSX Venture: IBT) today reported its financial results for the second quarter and the six months ended January 31, 2024.
Read full article »
IBEX is a Canada-based pharmaceutical company that manufactures and markets protein enzyme reagents for in-vitro diagnostics and research applications.
Read more